Literature DB >> 9477051

Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group.

E P Stover1, L C Siegel, R Parks, J Levin, S C Body, R Maddi, M N D'Ambra, D T Mangano, B D Spiess.   

Abstract

BACKGROUND: An estimated 20% of allogeneic blood transfusions in the United States are associated with cardiac surgery. National consensus guidelines for allogeneic transfusion associated with coronary artery bypass graft (CABG) surgery have existed since the mid- to late 1980s. The appropriateness and uniformity of institutional transfusion practice was questioned in 1991. An assessment of current transfusion practice patterns was warranted.
METHODS: The Multicenter Study of Perioperative Ischemia database consists of comprehensive information on the course of surgery in 2,417 randomly selected patients undergoing CABG surgery at 24 institutions. A subset of 713 patients expected to be at low risk for transfusion was examined. Allogeneic transfusion was evaluated across institutions. Institution as an independent risk factor for allogeneic transfusion was determined in a multivariable model.
RESULTS: Significant variability in institutional transfusion practice was observed for allogeneic packed red blood cells (PRBCs) (27-92% of patients transfused) and hemostatic blood components (platelets, 0-36%; fresh frozen plasma, 0-36%; cryoprecipitate, 0-17% of patients transfused). For patients at institutions with liberal rather than conservative transfusion practice, the odds ratio for transfusion of PRBCs was 6.5 (95% confidence interval [CI], 3.8-10.8) and for hemostatic blood components it was 2 (95% CI, 1.2-3.4). Institution was an independent determinant of transfusion risk associated with CABG surgery.
CONCLUSIONS: Institutions continue to vary significantly in their transfusion practices for CABG surgery. A more rational and conservative approach to transfusion practice at the institutional level is warranted.

Entities:  

Mesh:

Year:  1998        PMID: 9477051     DOI: 10.1097/00000542-199802000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  33 in total

1.  Report from AmSECT's International Consortium for Evidence- Based Perfusion Consensus Statement: Minimal Criteria for Reporting Cardiopulmonary Bypass-Related Contributions to Red Blood Cell Transfusions Associated With Adult Cardiac Surgery.

Authors:  Donald S Likosky; Robert A Baker; Timothy A Dickinson; Daniel J FitzGerald; M Filip De Somer; Robert C Groom; David FitzGerald; Kenneth G Shann; Michael Poullis; Bruce D Spiess; Karim Jabr; Mark T Lucas; James D Ferguson; Shahna L Bronson
Journal:  J Extra Corpor Technol       Date:  2015-06

2.  Balancing the benefits and risks of blood transfusions in patients undergoing cardiac surgery: a propensity-matched analysis.

Authors:  Richard E Shaw; Christopher K Johnson; Giovanni Ferrari; Alex Zapolanski; Mariano Brizzio; Nancy Rioux; Srinivasa Edara; Jason Sperling; Juan B Grau
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-03-28

3.  [Preoperative autologous blood donation in cardiac surgery. Reduction of allogeneic blood requirements].

Authors:  W Dietrich; R Busley; M Kriner
Journal:  Anaesthesist       Date:  2006-07       Impact factor: 1.041

4.  Blood component use and associated costs after standard dose chemotherapy--a prospective analysis of routine hospital care in lymphoproliferative disorders and NSCLC in Germany.

Authors:  Bernadette Paessens; Angela Ihbe-Heffinger; Christoph von Schilling; Rita Shlaen; Rudolf Bernard; Christian Peschel; Wolfgang Schramm; Karin Berger
Journal:  Support Care Cancer       Date:  2011-05-12       Impact factor: 3.603

5.  Thrombography reveals thrombin generation potential continues to deteriorate following cardiopulmonary bypass surgery despite adequate hemostasis.

Authors:  Raymond K Wong; Joseph R Sleep; Allison J Visner; David J Raasch; Louis A Lanza; Patrick A DeValeria; Antonio S Torloni; Francisco A Arabia
Journal:  J Extra Corpor Technol       Date:  2011-03

Review 6.  Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery.

Authors:  D C Peters; S Noble
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

7.  Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial.

Authors:  George Vretzakis; Athina Kleitsaki; Konstantinos Stamoulis; Metaxia Bareka; Stavroula Georgopoulou; Menelaos Karanikolas; Athanasios Giannoukas
Journal:  J Cardiothorac Surg       Date:  2010-02-24       Impact factor: 1.637

8.  Influence of intraoperative fluid volume on cardiopulmonary bypass hematocrit and blood transfusions in coronary artery bypass surgery.

Authors:  Jeffrey A Campbell; David W Holt; Valerie K Shostrom; Samuel J Durham
Journal:  J Extra Corpor Technol       Date:  2008-06

9.  Predictors of packed red cell transfusion after isolated primary coronary artery bypass grafting--the experience of a single cardiac center: a prospective observational study.

Authors:  Elsayed M Elmistekawy; Lee Errett; Hosam F Fawzy
Journal:  J Cardiothorac Surg       Date:  2009-05-07       Impact factor: 1.637

10.  Hospital variation in transfusion and infection after cardiac surgery: a cohort study.

Authors:  Mary A M Rogers; Neil Blumberg; Sanjay Saint; Kenneth M Langa; Brahmajee K Nallamothu
Journal:  BMC Med       Date:  2009-07-31       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.